APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin E2 Receptor EP2 Subtype

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prostaglandin E2 Receptor EP2 Subtype Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchProstaglandin E2 Receptor EP2 Subtype Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin E2 Receptor EP2 Subtype Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Prostaglandin E2 Receptor EP2 Subtype Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin E2 Receptor EP2 Subtype Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin E2 Receptor EP2 Subtype Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Prostaglandin E2 Receptor EP2 Subtype market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Prostaglandin E2 Receptor EP2 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prostaglandin E2 Receptor EP2 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prostaglandin E2 Receptor EP2 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prostaglandin E2 Receptor EP2 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Prostaglandin E2 Receptor EP2 Subtype include Sanofi, Santen Pharmaceutical Co., Ltd., Amgen Inc., Ono Pharmaceutical Co., Ltd. and Ascendis Pharma A/S, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Prostaglandin E2 Receptor EP2 Subtype, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostaglandin E2 Receptor EP2 Subtype, also provides the revenue of main regions and countries. Of the upcoming market potential for Prostaglandin E2 Receptor EP2 Subtype, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostaglandin E2 Receptor EP2 Subtype revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostaglandin E2 Receptor EP2 Subtype market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Prostaglandin E2 Receptor EP2 Subtype revenue, projected growth trends, production technology, application and end-user industry.

Prostaglandin E2 Receptor EP2 Subtype Segment by Company

Sanofi

Santen Pharmaceutical Co., Ltd.

Amgen Inc.

Ono Pharmaceutical Co., Ltd.

Ascendis Pharma A/S

Prostaglandin E2 Receptor EP2 Subtype Segment by Type

Treprostinil

TG-4155

SAR-366234

ONO-8055

Others

Prostaglandin E2 Receptor EP2 Subtype Segment by Application

Clinic

Hospital

Others

Prostaglandin E2 Receptor EP2 Subtype Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin E2 Receptor EP2 Subtype market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin E2 Receptor EP2 Subtype and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin E2 Receptor EP2 Subtype.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Prostaglandin E2 Receptor EP2 Subtype in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Prostaglandin E2 Receptor EP2 Subtype company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostaglandin E2 Receptor EP2 Subtype revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Treprostinil Major Player Table 3. TG-4155 Major Player Table 4. SAR-366234 Major Player Table 5. ONO-8055 Major Player Table 6. Others Major Player Table 7. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Player Table 9. Hospital Major Player Table 10. Others Major Player Table 11. Prostaglandin E2 Receptor EP2 Subtype Industry Trends Table 12. Prostaglandin E2 Receptor EP2 Subtype Industry Drivers Table 13. Prostaglandin E2 Receptor EP2 Subtype Industry Opportunities and Challenges Table 14. Prostaglandin E2 Receptor EP2 Subtype Industry Restraints Table 15. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Region (2021-2026) Table 18. Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Region (2027-2032) Table 20. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Players (2021-2026) Table 22. Global Prostaglandin E2 Receptor EP2 Subtype Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Prostaglandin E2 Receptor EP2 Subtype Key Players Headquarters & Area Served Table 24. Global Prostaglandin E2 Receptor EP2 Subtype Players, Product Type & Application Table 25. Global Prostaglandin E2 Receptor EP2 Subtype Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Prostaglandin E2 Receptor EP2 Subtype by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2021-2026) Table 32. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2027-2032) Table 33. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2021-2026) Table 37. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2027-2032) Table 38. Sanofi Company Information Table 39. Sanofi Business Overview Table 40. Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Sanofi Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 42. Sanofi Recent Development Table 43. Santen Pharmaceutical Co., Ltd. Company Information Table 44. Santen Pharmaceutical Co., Ltd. Business Overview Table 45. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 47. Santen Pharmaceutical Co., Ltd. Recent Development Table 48. Amgen Inc. Company Information Table 49. Amgen Inc. Business Overview Table 50. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 52. Amgen Inc. Recent Development Table 53. Ono Pharmaceutical Co., Ltd. Company Information Table 54. Ono Pharmaceutical Co., Ltd. Business Overview Table 55. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 57. Ono Pharmaceutical Co., Ltd. Recent Development Table 58. Ascendis Pharma A/S Company Information Table 59. Ascendis Pharma A/S Business Overview Table 60. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product Portfolio Table 62. Ascendis Pharma A/S Recent Development Table 63. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 66. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 67. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 68. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (US$ Million) Table 69. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (US$ Million) & (2027-2032) Table 70. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 71. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 72. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 73. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 74. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (US$ Million) & (2027-2032) Table 77. China Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 78. China Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 79. China Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 80. China Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 82. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 83. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 84. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 85. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 86. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (US$ Million) & (2021-2026) Table 87. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (US$ Million) & (2027-2032) Table 88. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 89. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 90. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 91. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 92. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (US$ Million) Table 94. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (US$ Million) & (2027-2032) Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Prostaglandin E2 Receptor EP2 Subtype Image Figure 2. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Share 2021 VS 2025 VS 2032 Figure 4. Treprostinil Image Figure 5. TG-4155 Image Figure 6. SAR-366234 Image Figure 7. ONO-8055 Image Figure 8. Others Image Figure 9. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Others Image Figure 14. Global Prostaglandin E2 Receptor EP2 Subtype Market Size (US$ Million) & (2021-2032) Figure 15. Global Prostaglandin E2 Receptor EP2 Subtype Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Prostaglandin E2 Receptor EP2 Subtype Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2021-2032) Figure 22. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2021-2032) Figure 25. North America Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032) Figure 27. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032) Figure 28. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2021-2032) Figure 29. United States Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032) Figure 34. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032) Figure 35. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2021-2032) Figure 36. Germany Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032) Figure 46. China Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032) Figure 47. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032) Figure 49. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032) Figure 50. Asia Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Region (2021-2032) Figure 51. Japan Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032) Figure 59. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032) Figure 60. SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2021-2032) Figure 61. Brazil Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Prostaglandin E2 Receptor EP2 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Treprostinil
  • TG-4155
  • SAR-366234
  • ONO-8055
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Sanofi
  • Santen Pharmaceutical Co., Ltd.
  • Amgen Inc.
  • Ono Pharmaceutical Co., Ltd.
  • Ascendis Pharma A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostaglandin E2 Receptor EP2 Subtype Market by Type
  3. 1.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Treprostinil
  5. 1.2.3 TG-4155
  6. 1.2.4 SAR-366234
  7. 1.2.5 ONO-8055
  8. 1.2.6 Others
  9. 1.3 Prostaglandin E2 Receptor EP2 Subtype Market by Application
  10. 1.3.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Prostaglandin E2 Receptor EP2 Subtype Market Dynamics
  1. 2.1 Prostaglandin E2 Receptor EP2 Subtype Industry Trends
  2. 2.2 Prostaglandin E2 Receptor EP2 Subtype Industry Drivers
  3. 2.3 Prostaglandin E2 Receptor EP2 Subtype Industry Opportunities and Challenges
  4. 2.4 Prostaglandin E2 Receptor EP2 Subtype Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Perspective (2021-2032)
  2. 3.2 Global Prostaglandin E2 Receptor EP2 Subtype Growth Trends by Region
  3. 3.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region (2021-2026)
  5. 3.2.3 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Players
  2. 4.1.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Players (2021-2026)
  3. 4.1.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Prostaglandin E2 Receptor EP2 Subtype Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostaglandin E2 Receptor EP2 Subtype Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Prostaglandin E2 Receptor EP2 Subtype Key Players Headquarters & Area Served
  7. 4.4 Global Prostaglandin E2 Receptor EP2 Subtype Players, Product Type & Application
  8. 4.5 Global Prostaglandin E2 Receptor EP2 Subtype Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Prostaglandin E2 Receptor EP2 Subtype Market CR5 and HHI
  11. 4.6.3 2025 Prostaglandin E2 Receptor EP2 Subtype Tier 1, Tier 2, and Tier 3
5 Prostaglandin E2 Receptor EP2 Subtype Market Size by Type
  1. 5.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2032)
  3. 5.3 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2021-2032)
6 Prostaglandin E2 Receptor EP2 Subtype Market Size by Application
  1. 6.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2032)
  3. 6.3 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Santen Pharmaceutical Co., Ltd.
  8. 7.2.1 Santen Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Santen Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  12. 7.2.5 Santen Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Amgen Inc.
  14. 7.3.1 Amgen Inc. Company Information
  15. 7.3.2 Amgen Inc. Business Overview
  16. 7.3.3 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  18. 7.3.5 Amgen Inc. Recent Developments
  19. 7.4 Ono Pharmaceutical Co., Ltd.
  20. 7.4.1 Ono Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Ono Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  24. 7.4.5 Ono Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Ascendis Pharma A/S
  26. 7.5.1 Ascendis Pharma A/S Company Information
  27. 7.5.2 Ascendis Pharma A/S Business Overview
  28. 7.5.3 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product Portfolio
  30. 7.5.5 Ascendis Pharma A/S Recent Developments
8 North America
  1. 8.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue (2021-2032)
  2. 8.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2032)
  3. 8.2.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026)
  4. 8.2.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032)
  5. 8.3 North America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032)
  6. 8.4 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2032)
  7. 8.4.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026)
  8. 8.4.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032)
  9. 8.5 North America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032)
  10. 8.6 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country
  11. 8.6.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026)
  13. 8.6.3 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue (2021-2032)
  2. 9.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2032)
  3. 9.2.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026)
  4. 9.2.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032)
  5. 9.3 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032)
  6. 9.4 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2032)
  7. 9.4.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026)
  8. 9.4.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032)
  9. 9.5 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032)
  10. 9.6 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country
  11. 9.6.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026)
  13. 9.6.3 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Prostaglandin E2 Receptor EP2 Subtype Revenue (2021-2032)
  2. 10.2 China Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2032)
  3. 10.2.1 China Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026)
  4. 10.2.2 China Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032)
  5. 10.3 China Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032)
  6. 10.4 China Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2032)
  7. 10.4.1 China Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026)
  8. 10.4.2 China Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032)
  9. 10.5 China Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue (2021-2032)
  2. 11.2 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2032)
  3. 11.2.1 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026)
  4. 11.2.2 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032)
  5. 11.3 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032)
  6. 11.4 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2032)
  7. 11.4.1 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026)
  8. 11.4.2 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032)
  9. 11.5 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032)
  10. 11.6 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Country
  11. 11.6.1 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026)
  13. 11.6.3 Asia Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue (2021-2032)
  2. 12.2 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2027-2032)
  5. 12.3 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2027-2032)
  9. 12.5 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country
  11. 12.6.1 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst